Yıl: 2018 Cilt: 27 Sayı: 1 Sayfa Aralığı: 38 - 42 Metin Dili: İngilizce İndeks Tarihi: 07-05-2019

The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection

Öz:
Aim: Our aim was to compare the choroidal thickness in patients with chronic hepatitis B virus (HBV) infection and age- and gen-der-matched healthy volunteers.Materials and Methods: A total of 69 chronic HBV infection cases and 64 age- and gender-matched controls were evaluated. The chronicHBV infection cases were divided into two subgroups as inactive carriers (38 cases) and those being treated (31 cases). The right eye wasevaluated in all subjects. The sections were measured horizontally across the fovea at 500-μm intervals using enhanced depth imagingoptical coherence tomography. The measurements were made at a total of 7 measurement points up to 1500 μm nasal and temporal to thefovea.Results: There was no signifi cant difference between the patient and control groups in terms of age, gender, body mass index, intraocularpressure and spherical equivalent (p>0.05). Choroidal thicknesses in chronic HBV patients were thicker than in the controls but thisdifference was not statistically signifi cant (p>0.05). There was no signifi cant correlation between disease duration and choroidal thickness.There was also no signifi cant difference between the subgroups for choroidal thickness (p>0.05).Conclusions: We found that the choroidal thicknesses were higher in chronic HBV patients than in healthy control subjects at allmeasurement points but these differences were not statistically signifi cant. The effect of chronic HBV infection on choroidal vascularstructures is not at a signifi cant level that can be determined with EDI-OCT.
Anahtar Kelime:

Konular: Göz Hastalıkları

Kronik Hepatit B Virus Enfeksiyonu Olan Hastalarda Koroidal Kalınlığın Değerlendirilmesi

Öz:
Amaç: Kronik hepatit B virus (HBV) enfeksiyonu olan hastalar ile yaş ve cinsiyet yönünden benzer sağlıklı gönüllüler arasında koroidal kalınlığı karşılaştırmaktır. Materyal ve Metod: Toplam 69 kronik HBV enfeksiyon olgusu ve 64 yaş ve cinsiyet benzer özellikte kontrol değerlendirildi. Kronik HBV enfeksiyon olguları inaktif taşıyıcılar (38 olgu) ve tedavi olanlar (31 olgu) olarak iki alt gruba ayrıldı. Tüm olgularda sağ göz değerlendirildi. Kesitler, geliştirilmiş derinlemesine görüntüleme optik koherens tomografi kullanılarak 500 μm aralıklarla fovea boyunca horizontal olarak ölçüldü. Foveada ve nazal ve temporalde horizontal olarak foveadan 500 μm aralıklarla 1500 mikrometreye kadar toplam 7 noktada ölçümler yapıldı. Bulgular: Hasta ve kontrol gruplar arasında yaş, cinsiyet, vücut kitle endeksi, göz içi basıncı ve sferik eşdeğer açısından anlamlı farklılık yoktu (p>0.05). Koroidal kalınlık kronik HBV hastalarında daha kalın bulundu, fakat bu farklılık istatistiksel olarak anlamlı değildi (p>0.05). Hastalık süresi ve koroidal kalınlık arasında anlamlı bir korelasyon yoktu. Alt gruplar arasında koroidal kalınlık açısından da anlamlı farklılık yoktu (p>0.05). Sonuç: Kronik HBV hastalarında koroidal kalınlığı tüm ölçüm noktalarında sağlıklı kontrollerden daha kalın bulduk, fakat bu farklılık istatistiksel olarak anlamlı değildi. Kronik HBV enfeksiyonunun koroidal damar yapıları üzerine etkisi EDI-OCT ile saptanabilen anlamlı bir düzeyde değildir.
Anahtar Kelime:

Konular: Göz Hastalıkları
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • Lavanchy D. Hepatitis B virus epidemiology, disease burden, tre- atment, and current and emerging prevention and control measu- res. J Viral Hepat 2004; 11: 97-107.
  • Lai CL, Yuen MF. Chronic hepatitis B-new goals, new treatment. N Engl J Med 2008; 359: 2488-91.
  • Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008; 146: 496-500.
  • Polat OA, Sinim N, Öner A. Choroidal thickness in dry age-related macular degeneration. Ret-Vit 2013; 21: 265-8.
  • Ceylan C, Yılmaz YC, Özer MD, et al. Choroidal Thickness Measurement and Relationship Between Choroidal Thickness and Axial Length, Spherical Equivalent and Age in Highly Myopic Eyes. Ret-Vit 2015; 23: 317-20.
  • Chung SE, Kang SW, Lee JH, et al. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 2011; 118: 840-45.
  • Toprak I, Yaylalı V, Yildirim C. Age-based analysis of choroidal thickness and choroidal vessel diameter in primary open-angle glaucoma. Int Ophthalmol. 2016; 36: 171-7.
  • Unsal E, Eltutar K, Zirtiloğlu S, et al. Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol 2014; 8: 637- 42.
  • Ahn SJ, Woo SJ, Park KH. Retinal and choroidal changes with severe hypertension and their association with visual outcome. Invest Ophthalmol Vis Sci 2014; 55: 7775-85.
  • Tunçbilek S. Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection. World J Gastroenterol 2014; 20: 6226-35.
  • Mrejen S, Spaide RF. Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol 2013; 58: 387-429.
  • Tuncer İ, Karahan E, Zengin MÖ. Subfoveal choroidal thickness in normal eyes measurement using optical coherence tomography. Ret-Vit 2014; 22: 137-9.
  • Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina 2011; 31: 502-9.
  • Öner A, Sinim N, Arda H, et al. Central choroidal thickness in eyes with central serous chorioretinopathy: the effect of disease activity. Ret-Vit 2016; 24: 124-8.
  • Ulaş F, Doğan Ü, Keleş A, et al. Evaluation of choroidal and retinal thickness measurements using optical coherence tomography in non-diabetic haemodialysis patients. Int Ophthalmol. 2013; 33: 533-9.
  • Zengin MÖ, Karahan E, Özyurtlu F, et al. The Effect of Blood Pressure Regulation on Choroidal Thickness. Ret-Vit 2014; 22: 213-6.
  • Kola M, Kalkisim A, Karkucak M, et al. Evaluation of choroidal thickness in ankylosing spondylitis using optical coherence tomography. Ocul Immunol Infl amm 2014; 22: 434-8.
  • Onal IK, Yuksel E, Bayrakceken K, et al. Measurement and clinical implications of choroidal thickness in patients with infl ammatory bowel disease. Arq Bras Oftalmol 2015; 78: 278-2.
  • Kılıç R, Kurt A, Acer E, et al. Choroidal thickness in psoriasis. Int Ophthalmol. 2017; 37: 173-7.
  • Balmasova IP, Yushchuk ND, Mynbaev OA, et al. Immunopathogenesis of chronic hepatitis B. World J Gastroenterol 2014; 20: 14156-71.
  • Cacoub P, Saadoun D, Bourlıère M, et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 2005; 43: 764-70.
  • Koksal I, Cetınkaya K, Aker F. Hepatitis B surface antigen in tears and aqueous humor: a comparative study of serum hepatitis B surface antigen levels. Ophthalmologica 1992; 204: 19-22.
  • Tsaı CY, Lın CL, Lın SC, et al. Detection of hepatitis B virus in the aqueous humor of a hepatitis B virus carrier. Ophthalmologica 2009; 223: 93-5.
  • Roh MI, Kim JH, Byeon SH, et al. Estimated prevalence and risk factor for agerelated maculopathy. Yonsei Med J 2008; 49: 931-41.
  • Cho BJ, Heo JW, Kim TW, et al. Prevalence and risk factors of age- related macular degeneration in Korea: the Korea National Health and Nutrition Examination Survey 2010-2011. Invest Ophthalmol Vis Sci 2014; 55: 1101-8.
  • Park SJ, Lee JH, Woo SJ, et al. Epidemiologic Survey Committee of the Korean Ophthalmologic Society. Age-related macular degeneration: prevalence and risk factors from Korean National Health and Nutrition Examination Survey, 2008 through 2011. Ophthalmology 2014; 121: 1756-65.
  • Singh VH, Kalra HK, Yamaki K, et al. Moleculer mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats. J Immunol 1990; 144: 1282-7.
  • Strobbe E, Cellini M, Campos EC. Aqueous fl are and choroidal thickness in patients with chroniic hepatitis C virus infection: a pilot study. Ophthalmology 2013; 120: 2258-63.
APA KILIÇ R, Kurt A, ERGÜL B (2018). The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. , 38 - 42.
Chicago KILIÇ Raşit,Kurt Ali,ERGÜL BİLAL The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. (2018): 38 - 42.
MLA KILIÇ Raşit,Kurt Ali,ERGÜL BİLAL The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. , 2018, ss.38 - 42.
AMA KILIÇ R,Kurt A,ERGÜL B The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. . 2018; 38 - 42.
Vancouver KILIÇ R,Kurt A,ERGÜL B The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. . 2018; 38 - 42.
IEEE KILIÇ R,Kurt A,ERGÜL B "The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection." , ss.38 - 42, 2018.
ISNAD KILIÇ, Raşit vd. "The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection". (2018), 38-42.
APA KILIÇ R, Kurt A, ERGÜL B (2018). The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. Retina-Vitreus, 27(1), 38 - 42.
Chicago KILIÇ Raşit,Kurt Ali,ERGÜL BİLAL The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. Retina-Vitreus 27, no.1 (2018): 38 - 42.
MLA KILIÇ Raşit,Kurt Ali,ERGÜL BİLAL The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. Retina-Vitreus, vol.27, no.1, 2018, ss.38 - 42.
AMA KILIÇ R,Kurt A,ERGÜL B The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. Retina-Vitreus. 2018; 27(1): 38 - 42.
Vancouver KILIÇ R,Kurt A,ERGÜL B The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection. Retina-Vitreus. 2018; 27(1): 38 - 42.
IEEE KILIÇ R,Kurt A,ERGÜL B "The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection." Retina-Vitreus, 27, ss.38 - 42, 2018.
ISNAD KILIÇ, Raşit vd. "The Evaluation of Choroidal Thickness in Patients With Chronic Hepatitis B Virus Infection". Retina-Vitreus 27/1 (2018), 38-42.